Communicable Disease Contacts in Regional Offices
1. WHO REGIONAL OFFICE FOR AFRICA (AFRO)
Member states
|
|
|
Contacts
Dr D. Barakamfitiye, Director, Prevention and Control of Diseases (DDC), Direct
telephone
1 407 953 92 29, fax 1 407 953 9413
Dr A. Ndikuyeze, A/Regional Adviser, Prevention and Control of Diseases (DDC),
Direct telephone: 1 407 953 92 45
E-mail:
Note: Following the temporary closure of the AFRO office in Brazzaville, the above contact information may not be valid. A temporary office is available in Harare
Tel: 263 4 706 951/707 493 Fax: 263 4 705 619/702 044
If you experience any difficulties in communicating with AFRO regarding disease surveillance issues, please contact EMC at WHO, Geneva, at tel. 41 22 791 21 11 / 2661
2. WHO REGIONAL OFFICE FOR THE AMERICAS (AMRO, PAHO)
Member states
|
|
|
* Associate Member
Contacts
Dr S. Corber, Director, Division of Communicable Disease Prevention and Control (HCP)
Direct telephone 001 202 974-3850, fax 001 202 974-3648 or 001 202 974-3643
E-mail: CORBERST@PAHO.ORG
Dr G. Schmunis, Coordinator, Programme of Communicable Diseases (HCP/HCT)
Direct telephone 001 202 974-3272 fax 001 202 861-8483 E-mail: SCHMUNIG@PAHO.ORG
3. WHO REGIONAL OFFICE FOR THE EASTERN MEDITERRANEAN (EMRO)
Member states
|
|
|
Contacts
Dr M.H. Wahdan, Assistant Regional Director
Direct tel. 00 203 483 0039; fax 00 203 48 21 545 E-mail: WAHDANM@WHO.SCI.EG
Dr B. Sadrizadeh, Director, Integrated Control of Diseases
fax 00 203 4838916 E-mail: SADRIZADEB@WHO.SCI.EG
Dr Z. Hallaj, RA/CDS
Direct telephone 00 203 4830096 direct fax 00 203 4838916 E-mail:HALLAJZ@WHO.SCI.EG
4. WHO REGIONAL OFFICE FOR EUROPE (EURO)
Member states
|
|
|
Contacts
Professor S. Dittman, Coordinator, Communicable Diseases and Immunization and Vaccine
Programme (CDI)
Direct telephone 00 45 39 17 13 98 or 00 45 39 17 14 15 (secretariat)
fax: 00 45 39 17 18 51 E-mail: SDI@WHO.DK
5. WHO REGIONAL OFFICE FOR SOUTH-EAST ASIA (SEARO)
Member states
|
|
|
Contacts
Acting Director, Integrated Control of Diseases (ICD)
fax: 00 91 11 331 8412
Dr A.G. Andjaparidze, Regional Adviser on Communicable Diseases (CDA)
Direct telephone: 00 91 11 331 7804 to 7823 Fax: 00 91 11 331 8412 E-mail: ANDJA@WHO.ERNET.IN
Dr Sawat Ramaboot, Regional Epidemiologist, Division of Integrated Communicable Diseases
(ICD) , Direct telephone: 00 9111 331-7804 to 00 9111 331-7823
Fax: 00 9111 331-8412 and 00 9111 331-8607
E-mail: SAWAT@WHO.ERNET.IN
Summary of SEARO Regional Plan for communicable disease surveillance
The first priority is to achieve the eradication or elimination of diseases such as dracunculiasis (India), poliomyelitis and leprosy in the Region.
The second priority is the prevention and control of diseases, which are major public health problems in the Region, through the establishment of appropriate national and regional surveillance mechanisms.
The third priority is to undertake short-term and long-term actions to combat newly emerging diseases. Since speedy response is needed to effectively contain outbreaks, rapid response mechanisms need to be built into the surveillance system.
The following are regional strategies for the coming few years towards the prevention and control of communicable diseases:
6. WHO REGIONAL OFFICE FOR THE WESTERN PACIFIC (WPRO)
Member states
|
|
|
* Associate Member
Contacts
Dr Shigeru Omi, Director, Disease Prevention and Control (DPC)
Direct telephone 00 632 522-9961, fax 00632 521-1036 E-mail: OMIS@WHO.ORG.PH
Dr Kouichi Morita, Regional Adviser in Communicable Diseases, CDS(M)
Direct telephone 00 632 522 9964, fax 00 632 521 1036 E-mail: MORITAK@WHO.ORG.PH
Summary of WPRO Regional Plan for communicable disease surveillance
Poliomyelitis surveillance
Surveillance on antimicrobial resistance
STD/AIDS surveillance, including gonococcal infections
Surveillance on anti-malaria and anti-tuberculosis drug resistance
For other selected infectious diseases, annual or monthly cases are being reported to WPRO.
WPRO is also developing Creutzfeldt-Jacob disease surveillance mechanisms (CJD does not exist at present in the Region) as part of global CJD surveillance.